![The largest genetic study of eczema ever performed permitted a team of international researchers to identify ten previously unknown genetic variations that contribute to the development of the condition. [University of Gothenburg]](https://www.clinicalomics.com/wp-content/uploads/2019/01/344-356x220.jpeg "Largest Ever Genomic Study for Eczema Finds New Genetic Risk Factors")
![Individumed and Helomics will partner to develop biomarkers for analyzing human cancer biospecimens and annotated patient clinical data. [Source: Individumed]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1249-218x150.jpeg "Indivumed, Helomics Launch Cancer Biomarker Collaboration")
Indivumed, Helomics Launch Cancer Biomarker Collaboration
Indivumed and Helomics will partner to develop biomarkers for analyzing human cancer biospecimens and annotated patient clinical data
GIANT Consortium IDs Body Fat Distribution Genes
Team shows the first association of body-fat distribution, assessed by waist-to-hip ratio adjusted for BMI, with low-frequency variants
The Human Genome at 15: Researchers Who Were There Discuss the Human Genome Project
Based on the power of today's sequencing technology it is easy to overlook how monumental a task the HGP was when launched in 1990
Janssen, BiomX to Partner on Discovering Microbiome-Based IBD Biomarkers
Janssen will use BiomX's XMarker platform to stratify responders versus non-responders of inflammatory bowel disease therapeutics
![A comprehensive molecular analysis of 894 primary renal cell carcinomas resulted in nine subtypes defined by systematic analysis of five genomic data platforms. Each major histologic types represent substantial molecular diversity. Presumed actionable alterations include PI3K and immune checkpoint pathways. [Dr. Chad Creighton/Cell Reports]](https://www.clinicalomics.com/wp-content/uploads/2019/01/570-218x150.jpeg "Large Genomic Study Finds New Kidney Cancer Subtypes and Drug Targets")
Large Genomic Study Finds New Kidney Cancer Subtypes and Drug Targets
A new study found substantial molecular diversity among kidney cancers and some possible new drug targets.
Health Network Laboratories Buys CTGT, Adding Inherited Genetic Disorders MDx Testing Services
Deal adds Connective Tissue Gene Tests' more than 3,300 unique tests covering 1,000+ genes to HNL's molecular diagnostic testing services
Direct-to-Consumer Genetic Testing: Will It Go Away?
The NIH defines direct-to-consumer genetic tests (DTCs) as those aimed at consumers via television, print advertisements, or the Internet. Also known as at-home genetic...
From DNA to Diagnosis without Delay
The world’s first processor expressly designed to perform secondary analysis of next-generation sequencing data is relieving the bottleneck between sequencing and practical application. Setting...
![Illumina believes the iSeq 100 benchtop NGS instrument has the potential to democratize genomics. [Source: Illumina]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1420-218x150.jpeg "Illumina Aims for iSeq 100 to Democratize Genomic Research")
Illumina Aims for iSeq 100 to Democratize Genomic Research
At a price of just under $20,000, iSeq 100 "puts NGS within reach of virtually any lab" Illumina contends
Improving Cancer Genome Analysis
Oncologists are increasingly using information obtained from investigations of the tumor genome to find individualized therapies for patients. They specifically search the hereditary information...
